TDA
Live / Applied — Non-final action mailed (as of 11 Dec 2025)
What this means for you
Not registered yet, but its 10 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79396709
- Mark type
- Stylized text
- Filed
- 10 May 2024
- Attorney of record
- Edward M. Kriegsman
Goods and services
- Class 003 — Cosmetics and cleaning preparations: Washing and cleaning preparations, namely, washing creams; non-medicated toiletry preparations, non-medicated body care preparations; non-medicated body cleaning preparations; preparations for baths and showers, namely, shower and bath gel, shower and bath foam, bath creams, not for medical purposes, bath foam for babies; perfumery and fragrances; non-medicated body sprays; cleaning and air fragrancing preparations; essential oils and aromatic extracts; oral hygiene preparations, namely, toothpaste; deodorants and antiperspirants; hair care preparations and treatments; non-medicated skin care preparations; bath soaps and gels; gel eye masks; serums for cosmetic purposes; tissues impregnated with make-up removing preparations; beauty preparations, not for medical purposes, cosmetics in the form of creams, beauty serums, beauty care cosmetics, beauty milk, beauty balm creams; cosmetics and cosmetic preparations; cosmetic kits comprised of foundation, lipstick, and blush; cosmetic preparations for body care; cosmetic preparations for nail drying; cosmetics, not for medical purposes, cosmetics in the form of oils, ointments for cosmetic purposes; scalp treatments (non-medicated -); cosmetics for personal use
- Class 005 — Pharmaceuticals: Sanitary preparations and articles, namely, sanitary preparations for veterinary purposes; medical and veterinary preparations and articles, namely, transdermal and intradermal preparations for the delivery of dermatological, anti-inflammatory, regenerative and analgesic substances; pharmaceuticals and natural remedy preparations for the treatment of skin diseases, inflammatory and degenerative conditions, pain, and tissue regeneration; medicines for veterinary purposes, namely, anti-inflammatory, analgesic and regenerative preparations for topical or transcutaneous administration; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; injectable dermal filler; lotions for veterinary purposes; microbicides, antibiotics for veterinary use, anaesthetics, antiallergics, anti-bacterial preparations, antibiotics, antifungal creams for medical purposes, antihistamines, antimicrobial preparations, antimicrobials for dermatologic use, antifungal preparations; anticoagulants, anticonvulsants; medicines for veterinary purposes; medicines for dental purposes; autonomic drugs for medical purposes; allergy relief medication; medicinal creams for the protection of the skin; pharmaceutical preparations acting on the central nervous system; eye lotions for medical use; balms for pharmaceutical purposes, balsamic preparations for medical purposes; creams for dermatological use, anti-itch creams; anti-inflammatory preparations, anti-inflammatory ointments; topical gels for medical and therapeutic use, gels for dermatological use; anti-infective products for veterinary use; injectable pharmaceuticals for treatment of anaphylactic reactions; lotions for pharmaceutical purposes; medicated creams, medicated lotions, medicated ointments for application to the skin; nervines being pharmaceutical medicines for the treatment of stress-related and neuropathic pain disorders; pharmaceutical creams for the treatment of dermatological and inflammatory skin conditions including eczema, psoriasis and acne; tissue-regenerative pharmaceutical preparations, pharmaceutical antiallergic preparations and substances; pharmaceuticals, pharmaceutical products and preparations to prevent swelling in the legs, pharmaceutical preparations for treating skin disorders, pharmaceutical products for the treatment of infectious diseases, pharmaceutical products for the treatment of bone diseases, pharmaceutical preparations for the treatment of skeletomuscular disorders; pharmaceutical compositions for the treatment of pain, inflammation and degenerative joint diseases; pharmaceutical preparations for the treatment of dermatological, orthopedic and regenerative conditions; pharmaceutical preparations for peripheral nervous system, pharmaceutical preparations for the treatment of viral diseases, pharmaceutical preparations for treating sports injuries; pain relief preparations; oxygen for medical purposes; ointments for pharmaceutical purposes
- Class 010 — Medical apparatus: Medical and veterinary apparatus and instruments, namely, portable incubators featuring regulated oxygen, temperature and humidity for veterinary use; respiratory therapy instruments, namely, sterile disposable oxygen humidifiers and nebulizers for respiratory therapy sold prefilled with water; apparatus for use in vein puncture, namely, injection needles; aerosol dispensers for medical purposes, namely, inhalers for medical purposes, sold empty; apparatus for the treatment of breathing difficulties, namely, inhalers for therapeutic purposes, sold empty; applicators for medications; applicators for antibacterial preparations; applicators for pharmaceutical preparations; apparatus for the treatment of leg ulcers, namely, lasers for medical purposes; apparatus for producing oxygen for medical use
Owner
Prosecution history
- 11 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Dec 2025 — NON-FINAL ACTION E-MAILED
- 11 Dec 2025 — NON-FINAL ACTION WRITTEN
- 10 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 06 Nov 2025 — ASSIGNED TO EXAMINER
- 29 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 29 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 26 Jul 2025 — REFUSAL PROCESSED BY IB
- 01 Jul 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 30 Jun 2025 — REFUSAL PROCESSED BY MPU
- 22 Apr 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 21 Apr 2025 — NON-FINAL ACTION WRITTEN